Podcasts about Urology

In this episode "How can we optimise decision-making for complex/high-risk kidney stone patients?"  Prof. Bhaskar Somani (GB) is joined by Dr. Matthew Breeggemann (US) and Dr. Timothy Bryant (GB) to explore the practical value and challenges of multidisciplinary collaboration in stone disease management. The speakers reflect on how shared decision-making within a structured stone MDT can support better outcomes for complex or high-risk recurrent kidney stone patients. Using a real-life case example, they walk through the patient journey, examining how early specialist input and coordinated care can impact diagnosis, treatment planning and follow-up.They discuss the current gaps in guideline implementation, particularly where patient complexity demands input beyond standard urological care. The role of nephrology, radiology and dietetics in MDT decision-making is highlighted, emphasising the need for clear communication and flexible protocols. The speakers also address challenges, such as delays in imaging or conflicting clinical opinions and how MDT formats can help resolve these through consensus-building.The importance of tailoring care to individual risk profiles is underscored, along with suggestions for integrating MDT principles into both large and smaller healthcare systems. The episode concludes with practical recommendations for centres looking to establish or improve a stone MDT. This conversation provides valuable insight for clinicians involved in managing stone disease and those working toward more coordinated care models.You can also listen to the previously released episode:Identifying high-risk stone formers: How can we improve early diagnosis and referral? A discussion between Prof. Somani, Prof. Ferraro and Prof. EmilianiAcknowledgmentMedical writing support was provided by Accenture Song Life Sciences with unrestricted funding from Novo Nordisk, with no involvement in the programme or speaker selection.

In this episode, Ashutosh (Ash) K. Tewari, MD, Urologist and Prostate Cancer Specialist and Chairman of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai, discusses the rise in prostate cancer cases, strategies to reduce treatment-related side effects, and how mobile units are expanding outreach to improve patient access and early detection.

December 12, 2025 In this episode, Scott, Mark, and Ray Painter share highlights from the recent Urology Advanced Coding and Reimbursement Seminar in Las Vegas, including robust discussions on E/M coding, prostate biopsy changes, modifiers, and the Wiser program. They also provide an important update on the AMA's recent meeting about coding and payment for algorithmic services, detailing how CPT and the RUC are approaching AI integration in healthcare. From potential reimbursement models to risk assignment and FDA considerations, this forward-looking conversation covers the groundwork being laid for AI's role in clinical care and payment policy.Urology Advanced Coding and Reimbursement SeminarInformation and RegistrationPRS Coding and Reimbursement HubAccess the HubFree Kidney Stone Coding CalculatorDownload NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and AdminsPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.         https://www.prsnetwork.com/joinuptpClick Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

In this episode of AUANews Inside Tract, Census Trends, Dr. Catherine Nam and Dr. Hannah Glick explore key findings from the AUA Census on burnout among urologists, with nearly half reporting symptoms of stress. They discuss unhealthy coping mechanisms, the stigma around seeking mental health care, and how licensure policies may discourage physicians from getting help. The episode also offers actionable steps for physicians, administrators, and policymakers to support well-being and shift the culture around mental health in medicine.

This EAUN edition of EAU Podcasts presents the latest update of the intravesical instillation guidelines, featuring insights from experts Bente Thoft Jensen RN, PhD, Susanne Vahr Lauridsen RN, PhD, and Lisbeth Leinum RN, PhD.They discuss the key recommendations and changes since the previous version, as well as the impact on clinical practice, and how nurses and patients benefit from the guidelines. They also outline the evidence-based development process of the guidelines and highlight the focus on nurse and patient safety, education, risk stratification and management of complications. The speakers emphasise growing evidence on managing side effects and the increasing attention to patient perspectives and quality of life.A key message is the importance of improving patient adherence and ensuring nurses understand the differences between BCG and Mitomycin to maintain safety.-----Host: Lisbeth Leinum, EAUN board memberSpeakers: Bente Thoft Jensen, RN, senior researcher, chair of the Bladder Cancer SIG and the guideline panel; Susanne Vahr Lauridsen, RN, senior researcher, member of the guidelines panel.-----For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Edward M. Schaeffer, MD, PhD, moderates a thoughtful conversation with two former Northwestern Urology residents, Richard Matulewicz, MD, MSCI, MS, urologic surgeon at Memorial Sloan Kettering Cancer Center, and Neema Navai, MD, MHCM, professor and chair of the department of urology and special advisor to the chief physician executive for care development at MD Anderson Cancer Center. Together, they share insights from their professional journeys, explore the evolving landscape of urologic care and discuss how their experiences have shaped their career paths and approach to patient care.

In this episode, Dr. Ardeshir Rastinehad, Vice Chair of Urology at Northwell's Lenox Hill Hospital and System Director for Prostate Cancer at Northwell Health, discusses emerging trends and breakthroughs in prostate cancer screening, diagnosis, and treatment. He explains the focal therapy process—including cryotherapy—and shares insights on the mission and impact of the Focal Therapy Society.

In Episode 9, “The urology resident perspective” of the series “Women in urology: Dare to thrive”, Dr. Kim Pauwaert (BE) and Dr. Francesco Ripa (IT) offer an honest and personal look into the realities of residency from both female and male perspectives.Drawing on their training experiences in Belgium, Italy and the UK, they discuss the changing gender landscape in urology, the importance of visible role models and how mentorship shapes confidence and career choices.Dr. Pauwaert shares candid reflections on balancing demanding training with societal expectations placed on women, including the challenges of long hours, family responsibilities and concerns around pregnancy risks for surgical trainees.Together, they examine how work culture, flexibility and institutional support can improve the residency experience for all, regardless of gender. The episode closes with an optimistic view of the future, as both speakers note the growing presence of female urologists and the positive shift in patient and professional perceptions.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Geo Espinosa, ND, LAc, CNS, a well-known naturopathic doctor specializing in urological health at NYU Langone Hospital, and host of the upcoming Prostate Cancer Summit 2.0, scheduled for December 13th-17th, a free online event designed to provide comprehensive information on prostate cancer diagnosis, treatment, and management. 

Geo Espinosa, ND, LAc, CNS, a well-known naturopathic doctor specializing in urological health at NYU Langone Hospital, licensed acupuncturist, and certified Functional Medicine practitioner, discusses prostate health, including the latest advances in prostate cancer treatment and the importance of a balanced approach between natural and conventional medicine. Dr. Espinosa also highlights the upcoming Prostate Cancer Summit 2.0, scheduled for December 13th-17th, a free online event designed to provide comprehensive information on prostate cancer diagnosis, treatment, and management. The conversation covers PSA testing, new diagnostic tools, advanced treatment options like androgen deprivation therapy, and the benefits of exercise and diet in managing prostate health.

Welcome to the Choosing Wisely Campaign series! This is the fifth and final episode of our 5-part series exploring the ABIM Foundation's Choosing Wisely Lists. This campaign aims to promote conversations between clinicians and patients to avoid unnecessary medical tests, treatments, and procedures. Our last case-based episode focuses on a school-aged male presenting with new-onset enuresis. After a discussion of the differential diagnosis and evidence-based evaluation strategies, we apply recommendations from multiple AAP Choosing Wisely lists to create a care plan that is safe, resource-conscious, and child-centered. Throughout this episode, we'll highlight how ethical care principles—beneficence, nonmaleficence, autonomy, and justice—guide high-value decision-making and help us avoid unnecessary imaging, laboratory studies, and interventions that add cost without improving outcomes. This familiar case in pediatrics is worthy of a rewind to relisten to a throwback episode that will reinforce your skills and emphasize the clinical diagnosis and management without added diagnostics, referrals, or medications.  This case closes out our series on Choosing Wisely in Pediatrics, but the principles we've explored should continue to inform your practice every day. If you missed earlier episodes, rewind to learn more about the campaign's background and listen to cases on fever and cough, gastroenterology presentations, and more.   Series Learning Objectives: Introduction to the Choosing Wisely Campaign: Understand the origins, historical precedent, and primary goals of the campaign. Case-Based Applications: Explore five common presentations in primary and acute care pediatrics, applying concepts from various Choosing Wisely lists to guide management and resource stewardship. Effective Communication: Learn strategies for engaging in tough conversations with parents and colleagues to create allies and ensure evidence-based practices are followed. Modified rMETRIQ Score: 15/15 What does this mean?   Competencies: AACN Essentials: 1: 1.1 g; 1.2 f; 1.3 d, e 2: 2.1 d, e; 2.2 g; 2.4 f, g; 2.5 h, i, j, k 7: 7.2 g, h, k 9: 9.1i, j; 9.2 i, j; 9.3 i, k NONPF NP Core Competencies: 1: NP 1.1h; NP 1.2 k, m; NP 1.3 f, j, h 2: NP 2.1 j, g; NP 2.2 k, n; NP 2.4 h, i; NP 2.5 k, l, m, n, o 7: NP 7.2 m 9: NP 9.1 m, n; NP 9.2 n; NP 9.3 p References: AAP Section on Emergency Medicine & Canadian Association of Emergency Physicians. (2022). Five things physicians and patients should question. Retrieved from https://downloads.aap.org/AAP/PDF/Choosing%20Wisely/CWEmergencyMedicine.pdf AAP Section on Gastroenterology, Hepatology, and Nutrition. (2023). Five things physicians and patients should question. https://downloads.aap.org/AAP/PDF/Choosing%20Wisely/CWGastroenterology.pdf AAP Section on Urology. (2022). Five things physicians and patients should question. Retrieved from https://downloads.aap.org/AAP/PDF/Choosing%20Wisely/CWUrology.pdf Daniel, M., Szymanik-Grzelak, H., Sierdziński, J., Podsiadły, E., Kowalewska-Młot, M., & Pańczyk-Tomaszewska, M. (2023). Epidemiology and Risk Factors of UTIs in Children-A Single-Center Observation. Journal of personalized medicine, 13(1), 138. https://doi.org/10.3390/jpm13010138 McMullen, P.C., Zangaro, G., Selzer, C., Williams, H. (2026). Nurse Practitioner Claims and the National Practitioner Data Bank: Trends, Analysis, and Implications for Nurse Practitioner Education and Practice. Journal for Nurse Practitioners, 22(1), p. 105569, https://doi-org.proxy.lib.duke.edu/10.1016/j.nurpra.2025.105569 Tabbers, M. M., DiLorenzo, C., Berger, M. Y., Faure, C., Langendam, M. W., Nurko, S., Staiano, A., Vandenplas, Y., Benninga, M. A., European Society for Pediatric Gastroenterology, Hepatology, and Nutrition, & North American Society for Pediatric Gastroenterology (2014). Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. Journal of pediatric gastroenterology and nutrition, 58(2), 258–274. https://doi.org/10.1097/MPG.0000000000000266 UCSF Benioff Children's Hospitals. (n.d.). Constipation & urologic problems. https://www.ucsfbenioffchildrens.org/conditions/constipation-and-urologic-problems Vaughan, D. (2015). The Challenger Launch Decision: Risky Technology, Deviance, and Culture at NASA. University of Chicago Press. DOI: 10.7208/chicago/9780226346960.001.0001 Wilbanks, Bryan A. PhD, DNP, CRNA. Evaluation of Methods to Measure Production Pressure: A Literature Review. Journal of Nursing Care Quality 35(2):p E14-E19, April/June 2020. | DOI: 10.1097/NCQ.0000000000000411

In Episode 8, “Inclusivity challenge: Creating transformative culture” of the series “Women in urology: Dare to thrive”, Dr. Joe Philip (GB) and Dr. Silvia Proietti (IT) explore what true inclusivity looks like in modern urology and how cultural transformation begins with everyday behaviours.Across their discussion, both speakers emphasise that inclusivity goes far beyond gender balance - it requires psychological safety, open communication and a willingness to question long-standing norms in surgical culture.They discuss the importance of positive role models, supportive senior colleagues and transparent opportunities for career development, noting how these elements can empower young urologists regardless of background. Practical strategies emerge throughout their conversation, including active mentorship, equitable access to the operating room and consciously amplifying underrepresented voices.Dr. Philip and Dr. Proietti also address the need for institutional commitment, reminding listeners that sustainable change depends on leadership engagement as much as individual effort. The episode ultimately offers a hopeful message: with intentional action and collective responsibility, urology can become a more inclusive, empowering and forward-thinking specialty.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Episode 4 of our monthly GU Cast Journal Club and today we focus on two important papers in prostate cancer diagnostics and bladder cancer surgery. The PRECISION NEJM paper 2018 is a landmark publication which defined the role of mpMRI in early detection, and changed practice in many countries. The EB-StaR trial should also change practice after its European Urology 2024 publication, but has it??!We are delighted to welcome back our GU Cast Journal Club Editors, Dr Carlos Delgado (Melbourne, AUS), and Dr Elena Berg (Munich, GER), along with main GU Cast Hosts, Renu Eapen and Declan Murphy. A very lively discussion!! Links to papers below:1. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis NEJM 20182. Transurethral En Bloc Resection Versus Standard Resection of Bladder Tumour: A Randomised, Multicentre, Phase 3 Trial Eur Urol 2024GU Cast Journal Club is supported by our Partner, MSD, through an unrestricted educational grant.Even better on our YouTube channelAbout GU Cast Journal Club:Each month, two papers are discussed, each of which are of importance to the GU Oncology community. These may be recent papers, or occasionally we will chose a classic landmark paper in GU Oncology. The objective is to draw attention to important papers in GU Oncology, and critique these in a robust manner. The key target audience is trainees working in Urology, Medical Oncology, Radiation Oncology, Nuclear Medicine, and diagnostic specialties such as Radiology and Pathology. But any of our regular audience are likely to enjoy this Journal Club series.

Why do so many indoor cats develop urinary disease? Meet Dr. Allison Kendall, Associate Professor of Internal Medicine at NC State and feline nephrology & urology specialist. In this episode of Purr Podcast, we talk pee, pain, FIC, minimally invasive procedures, and why the bladder is just the beginning when it comes to cat urinary disease.Thanks for tuning in to the Purr Podcast with Dr. Susan and Dr. Jolle!If you enjoyed today's episode, don't forget to subscribe, rate, and leave us a review—it really helps other cat lovers and vet nerds find the show. Follow us on social media for behind-the-scenes stories, cat trivia, and the occasional bad pun. And remember: every day is better with cats, curiosity, and maybe just a little purring in the background. Until next time—stay curious, stay kind, and give your cats an extra chin scratch from us. The Purr Podcast – where feline medicine meets feline fun.

The most common male infertility procedures are varicocele ligation, vasectomy reversal, and sperm retrieval for IVF. Peter Kolettis, M.D., a urologist, explains the purposes and steps of each procedure. He discusses working with colleagues in reproductive endocrinology to support each couple's goals. Learn how urologists counsel patients to understand the factors that influence success with fertility procedures.

In this EAU podcast episode, UROONCO PCa associate editor Dr. Pawel Rajwa (PL), talks to Prof. Thomas Zilli (CH) on local therapy in metastatic prostate cancer. This discussion was recorded at EMUC25. For more updates on prostate cancer, please visit our educational platform UROONCO PCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In Episode 7, “Imposter syndrome and resilience” of the series “Women in urology: Dare to thrive”, Dr. Silvia Secco (IT), Dr. Rianne Lammers (NL) and Dr. Guido Cereda (IT) share open and personal reflections on imposter syndrome and the many forms it takes throughout a urological career.They begin by acknowledging how common these feelings are - even among confident, accomplished clinicians - and discuss how new roles, transitions and increased responsibilities can intensify self-doubt.Drawing on their own experiences, they explore how comparison, perfectionism and fear of inadequacy affect both trainees and senior doctors, often quietly and persistently. The speakers highlight the importance of supportive colleagues, mentorship and honest conversations, emphasising how validation from peers can help break the isolation many feel.They also discuss practical approaches to building resilience, from reframing negative thoughts to recognising achievements and allowing space for vulnerability. Ultimately, the episode offers a reassuring message: imposter syndrome is widespread, manageable and best overcome together through openness, connection and shared understanding.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

What if your erection could tell you something deeper about your health—something even your doctor might miss?In this exclusive episode, Dr. Arthur Burnett, one of the leading experts in urology and a key figure in the science behind Viagra, joins the conversation. Together, we explore the real connection between erectile dysfunction, prostate cancer, and overall prostate health. We dive into what's fact, what's fiction, and why ED might be your body's first warning sign of something much bigger. Whether you're dealing with performance issues or concerned about your prostate, this episode is for you.Hit play now. Your health, and your future, may depend on it.--------------About Dr. Arthur BurnettDr. Arthur Burnett is a world-renowned urologist and professor at the Johns Hopkins School of Medicine, where he holds the prestigious Patrick C. Walsh Professorship in Urology. As Director of the Male Consultation Clinic and Vice Chair for faculty development at the James Buchanan Brady Urological Institute, he brings decades of groundbreaking expertise in erectile dysfunction, prostate cancer, and reconstructive urology.A pioneer in the discovery of nitric oxide's role in erections, Dr. Burnett's research was instrumental in the development of Viagra. He has performed over 3,000 nerve-sparing radical prostatectomies and authored more than 500 peer-reviewed publications. With honors from the NIH, FDA, and the American Urological Association, Dr. Burnett continues to lead the field in advancing male sexual and prostate health.Want to connect with Dr. Arthur Burnett? Visit the Johns Hopkins Urology website or find his books on Amazon to learn more about his work in men's health.--------------Resources mentioned:Modern Man CribMediterranean DietGood Morning Wood Smoothie--------------Curious about how you can boost your bedroom game and build lasting confidence? Check out the course at getwoodnow.com and start your journey to feeling like yourself again!--------------If you enjoyed this episode and want to learn more and get more tips, subscribe to The Modern Man newsletter for exclusive content delivered straight to your inbox! https://dranne.co/themodernman--------------Follow Me On:InstagramTwitterFacebookTikTokYouTube--------------For all links and resources mentioned on the show and where to subscribe to the podcast, please visit

UROONCO BCa associate editor Dr. Elisabeth Grobet-Jeandin (CH) and Dr. Laura Mertens (NL) interview Dr. Laura Bukavina (US) on managing high-risk non-muscle invasive bladder cancer (NMIBC). This interview was recorded at EMUC25 in Prague, Czech. For more updates on bladder cancer, please visit our educational platform UROONCO BCa.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

UROONCO RCC chief editor Dr. Carmen Mir (US) talks to Dr. Lorenzo Bianchi (IT) on his lecture "RCC with venous thrombosis: optimal imaging for surgical planning and imaging-guided surgery".This interview was recorded at EMUC25 in Prague. For more updates on kidney cancer, please visit our educational platform UROONCO RCC.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Pre-Order The Forever Strong PLAYBOOK and receive exclusive bonuses: https://drgabriellelyon.com/playbook/Want ad-free episodes, exclusives and access to community Q&As? Subscribe to Forever Strong Insider: https://foreverstrong.supercast.comIn this compilation episode, Dr. Gabrielle Lyon is joined by the top experts in Testosterone and men's health treatments. You'll learn:Why aging alone doesn't drop T levels and why acquisition of conditions like obesity is the real culprit.Why the standard "low T" cutoff is misleading and why you must check your Free Testosterone.How erectile dysfunction is a sensitive marker of overall health and heart risk.The efficacy of Cialis/Viagra for both erections and cardiac protection, and the risks of unchecked influencer advice on steroids.The direct link between muscle mass, exercise, and sexual function—and why the penis is the "first to go" when overall health declines.Chapter Markers:0:00 - Testosterone is a Brain Hormone0:40 - Debunking the Myth: Male Menopause (Andropause) Doesn't Exist1:33 - The Dangers of Unchecked Influencer Advice on Testosterone3:07 - Defining Testosterone Deficiency: Symptoms vs. Signs5:10 - The Arbitrary Number: Why Guidelines Disagree on Low T8:29 - Free Testosterone: The Most Reliable Indicator of Male Health15:28 - TRT vs. Steroids: Defining the Line and Risks18:59 - The Real Risks of TRT: Infertility and Hematocrit22:36 - The Shocking Backstory: Challenging the Prostate Cancer Myth26:40 - Erectile Dysfunction (ED) and Lifestyle Modification29:21 - Shockwave Therapy for ED: The Science and the Cash Business33:53 - Penile Tissue Atrophy and Venous Leak37:25 - The Role of Muscle Mass, Sarcopenia, and Sexual Function39:41 - The Single Best Marker for Male Health: Erectile Function42:02 - The Science of Cialis and Viagra (PDE5 Inhibitors)45:49 - The Viagra Story: From Heart Drug to ED Cure50:50 - Tadalafil (Cialis) as a Triple-Threat Drug (Cardiac, Urinary, Sexual)53:57 - The Role of Testosterone in Female Sexual Function55:20 - Hypogonadism: Diagnosis, Treatment, and Fertility RiskAbout the guests: Dr. Abraham Morgentaler is an Associate Clinical Professor of Urology at Harvard Medical School and founder of Men's Health Boston. He is an internationally recognized expert in men's health, particularly known for his pioneering work in testosterone therapy. Dr. Morgentaler is credited with reversing the long-held belief that testosterone therapy causes prostate cancer and is the author of several books on men's health. YouTubeLinkedInT4L EducationX/Twitter Dr. Tobias Kohler is the co-founder of the Erectile Restoration Outcomes Study (EROS) penile implant registry. In addition to his clinical and research activities, Dr. Kohler is active in education, providing mentorship to residents and fellows.Mayo Clinic ResearchGateLinkedIn

Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University. In the final part of this 3-part series, Dr Terris discussed how the early diagnosis of bladder cancer presents a significant challenge, particularly in female patients, who are frequently diagnosed at a later stage of the disease and subsequently respond less favorably to treatment modalities. A crucial component of early detection is the rigorous evaluation of hematuria, she emphasized. Microhematuria is defined strictly by microscopy. Reliance solely on a dipstick test is insufficient; any positive dipstick result necessitates a microscopic examination, she explained. Furthermore, patients currently receiving anticoagulation therapy do not bypass the standard workup, she noted. If hematuria is identified alongside a urinary tract infection or gynecological issue, the urine should be rechecked once the co-existing problem has cleared, she advised. Risk assessment must consider both common and less-recognized factors, particularly in women, according to Terris. Standard risks include exposure to cyclophosphamide or ifosfamide, Lynch syndrome, chronic indwelling Foley catheters, benzene/aromatic amine exposure, and smoking, she added. However, uro-oncologists must actively assess female patients for occupational exposures not traditionally associated with bladder cancer, she said. Patients presenting with microhematuria should be stratified into low-, intermediate-, or high-risk groups, Terris continued. The gold standard evaluation for high-risk patients is a cystoscopy and CT urogram, she reported. The CT urogram involves cross-sectional imaging of the abdomen and pelvis with and without contrast, incorporating delayed images to optimally visualize the renal pelvis and ureters for potential filling defects, she noted. If patients cannot tolerate contrast, an MR urogram is the primary alternative, she stated. If neither CT nor MR urogram can be performed, the default workup is non-contrast CT combined with cystoscopy and retrograde pyelograms, although this requires general anesthesia, she explained. Given that women are often diagnosed with bladder cancer late and face poor outcomes with advanced disease, maintaining a heightened awareness and low threshold for investigation is critical, Terris concluded.

UROONCO RCC associate editor Assoc. Prof. Carlotta Palumbo (IT) talks with medical oncologist Dr. Pasquale Rescigno (GB) about his presentation supporting the 'yes' position in the debate at EMUC25: “Is single agent TKI (tyrosine kinase inhibitor) still an option in selected mRCC patients? This interview was recorded at EMUC25 in Prague. For more updates on kidney cancer, please visit our educational platform UROONCO RCC.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

In Episode 6, “The mentor perspective: Welcoming diversity” of the series “Women in urology: Dare to thrive”, Dr. Michelle Jo Semins (US) and Prof. Bhaskar Somani (GB) share their insights on how mentorship can shape more inclusive and equitable professional environments.Drawing on their own experiences as mentor and mentee, they discuss how effective guidance can help overcome systemic barriers and support women in advancing their careers in urology. The conversation highlights the importance of recognising individual strengths, fostering confidence and creating opportunities that empower the next generation.Both speakers emphasise that mentorship is not only about professional growth but also about personal connection, trust and the shared responsibility to promote diversity across all levels of academia and clinical practice. Together, they offer a thoughtful reflection on how inclusive mentorship can drive real change in the culture of urology.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Are children's IQs going down?An overview of medical reversalsCan you comment on the melatonin and heart failure study?Result of a prostate artery embolization

I have hypothyroidism.  Do I need to be concerned about low ferritin levels?What are the benefits of lower-dose fish oil?Is there a connection between melatonin supplementation and depression?Can I take melatonin while on warfarin?What to do about the state of our healthcare system?

Our ‘Family Planning Division' has been busy! a few weeks ago it was Anne from Georgia playing ambulance driver with her post-vasectomy-reversal hubby moaning in the back seat. This time, Kara is pregnant with twins as a result of a botched vasectomy. Urology is a tougher racket than we thought. Boy have we got questions on this episode of the Best of Car Talk.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University. In part 2 of this 3-part series, Dr Terris discussed the disparities in treatment and outcomes for women with bladder cancer. Although bladder cancer is less common in females than in males, female patients tend to have significantly worse outcomes, Terris explained. Delayed diagnosis is a contributing factor, but the exact reasons for the poorer prognosis are not fully understood, she emphasized. Treatment difficulties begin surgically, according to Terris. From a surgical perspective, she noted that, performing a cystectomy on a woman is more challenging due to factors like pelvic varicosities and differing fat distribution, which complicate stoma creation. In terms of medical treatment, Terris also explained that women exhibit worse tolerability and higher rates of discontinuation of immunotherapy, and that they often experience poor efficacy outcomes regardless of whether they complete the course of treatment. These differences between men and women may be linked to factors such as hormonal influences or antibody introduction during pregnancy. Conversely, classic cisplatin-based neoadjuvant chemotherapy followed by radical cystectomy have been shown to have similar overall survival and disease-free survival in eligible female and male patients. Biologically, Terris also reported that tumors in women may exhibit more effective immune escape mechanisms, possibly connected to differences in the bladder microbiome. The presence of bacteria in bladder tumors has been found to be enriched in patients who did not respond to neoadjuvant chemotherapy, which is relevant as women are more prone to bladder colonization, she added. Overall, Terris emphasized that oncologists must be aggressive in treating women with bladder cancer, despite surgical complexities, and highlighted that early detection is key.

Urinary incontinence isn't “just part of getting older.” In this episode, Dr. Briana Walton, a urogynecologist at UM Capital Region Health, explains medical and surgical options to help, clears up myths, and shares why women don't have to live with bladder leaks in silence.  For more information about Dr. Walton 

In Episode 5, “Role Models in Academic Urology: The WUO Perspective” of the series “Women in Urology: Dare to Thrive”, Dr. Sarah Psutka and Dr. Sima Porten reflect on the role of mentorship, collaboration and visibility through the lens of the Women in Urologic Oncology (WUO). They discuss how WUO has become a platform for fostering diversity, leadership and professional growth, creating opportunities for women to contribute to academic excellence and clinical innovation.The speakers share how mentorship within WUO has helped strengthen global connections and inspired new generations of female urologists to pursue academic and leadership paths. They highlight the organisation's achievements in promoting inclusivity, scientific exchange and balanced representation in urologic oncology.This episode celebrates not only personal journeys but also the collective progress of women who are redefining academic success through shared purpose and collaboration.For more EAU podcasts, please go to your favourite podcast app and subscribe to our podcast channel for regular updates: Apple Podcasts, Spotify, EAU YouTube channel.

Urinary tract infections — or UTIs — aren't the most glamorous topic, but they're incredibly important, and we just don't talk about them enough. If you've ever had one, you'll know how miserable they can be: the burning, the stinging, those endless trips to the loo, the pain, and that bone-crushing fatigue. They can really knock you sideways.For many women, UTIs become more common — and more stubborn — during perimenopause and menopause.In this episode, I'm joined by the brilliant Helen Lake, a specialist urology nurse, to help us understand why UTIs happen, why they mustn't be ignored, and what you can do about them — from medical treatments to nutrition and supplements.Helen explains everything you need to know about identifying, understanding, and managing UTIs — and hopefully banishing them for good. We cover the key symptoms, prevention strategies like staying hydrated and double-voiding, why test results aren't always conclusive, and when antibiotics are needed. We also look at the role of beneficial bacteria, cranberry and D-mannose, vaginal moisturisers, topical oestrogen, and how to advocate for yourself with your GP.If you've found this episode helpful, please share it with a friend who might benefit too. And if you love The Happy Menopause podcast, I'd be so grateful if you could leave a five-star rating and a quick review on Apple Podcasts — or wherever you like to listen.And don't forget to subscribe, so you don't miss out on upcoming episodes. These small steps make a huge difference to the algorithm, and help more women find the show.After all, every woman deserves to have a happy menopause.Check out the full Show Notes for this episode on my website www.well-well-well.co.uk/podcast, where you'll find all the relevant links and references for each guest. Learn how to build your own menopause diet to manage your symptoms with my book The Happy Menopause: Smart Nutrition to Help You Flourish. And if you're tired of feeling tired and grappling with brain fog, check out my new book: The Happy Menopause Guide to Energy; Nutrition to Rejuvenate Your Brain & Body. It's available in all the usual places.

Considering a reconstructive urology fellowship or already in the thick of it? This episode is for you. Dr. Rachel Mann (University of Minnesota) sits down with Dr. George Koch (Ohio State University) to discuss her journey in reconstructive urology and the mentors who shaped it. Together, they explore how creativity, adaptability, and mentorship fuel progress in this evolving subspecialty.---SYNPOSISDr. Mann also shares practical advice for residents and fellows who are planning their next steps in training. She reflects on how to identify the right fellowship, make the most of a unique learning year, and transition effectively into independent practice. The episode closes with a discussion of the future of reconstructive urology, including global health opportunities, the potential for dedicated transgender surgery fellowships, and the mindset required to continue evolving as a reconstructive surgeon.---TIMESTAMPS00:00 - Introduction03:01 - Training and Mentorship11:09 - The Evolution and Scope of Reconstructive Urology32:49 - The Future of Reconstructive Urology35:01 - Expanding Internationally38:24 - Rapid Fire Advice for Residents45:59 - Advice for Fellows---RESOURCESThe Trauma and Urologic Reconstructive Network of Surgeons (TURNS)https://www.turnsresearch.org/Optilume ROBUST III trialhttps://bjui-journals.onlinelibrary.wiley.com/doi/10.1002/bco2.312RD-180 Suture Devicehttps://pubmed.ncbi.nlm.nih.gov/35070820/

Closing the Gap: Understanding Gender Disparities in Bladder Cancer Care, hosted by Martha K. Terris, MD, FACS, is a limited series spotlighting unique considerations for bladder cancer diagnosis and treatment among women. Dr Terris is department chair and a professor in the Department of Urology, the Witherington Distinguished Chair in Urology, and co-director of the Cancer Center at the Medical College of Georgia at Augusta University.  In part 1 of this 3-part series, Dr Terris discussed the prevalence of bladder cancer in women, as well as reasons for diagnostic disparities that contribute to poor treatment outcomes. She noted that this disease is often diagnosed at later stages in women than in men, often resulting in diagnoses of more advanced disease and translating to poorer outcomes. She added that although female patients represent a minority of those with urothelial carcinoma, retrospective data indicate that women tend to be diagnosed at later stages and consequently experience worse survival rates, regardless of the disease stage. Dr Terris identified several theories explaining why this diagnosis delay occurs. One possible reason is patient-related: women may be less likely than men to consult a physician when they notice blood in their urine because they may be conditioned to dismiss blood if they experience menstrual bleeding. However, physician behavior and bias also contribute to diagnostic disparities, Terris said. Women with suspected hematuria typically receive fewer imaging tests, she continued. Additionally, physicians may be biased, attributing hematuria to uterine bleeding, menstruation, or other benign causes.  Overall, Terris emphasized that early detection is key. If there is any suspicion of a malignancy, patients should be referred directly to a urologist, she stated. Urologists should be willing to work up cases that might ultimately be recurrent urinary tract infections or radiation cystitis to avoid undiagnosed cases of bladder cancer in women, she concluded.

Infertility isn't only a women's issue, though too often, it's talked about like it is. In this episode, we're digging into male factor infertility: what it means, how it's diagnosed, and how it impacts couples emotionally, physically, and relationally. We're joined by Paul Kassebaum, a quantum physicist, and his wife Julia Cohen, an economist, who live in Westchester, NY. In 2021, their family-building journey took an unexpected turn with a diagnosis of male factor infertility. They open up about the medical and emotional twists and turns of their path, and why they hope sharing their story will help others feel less alone. To give us a full picture, we also bring in experts: Dr. Ariel Moradzadeh, a reproductive endocrinologist, and Abbe Golding, a genetic counselor at Jscreen. Together, we explore: What male factor infertility actually is, what the causes are, and how it's evaluated Who should be doing the testing and why it matters The role genetics can play in male infertility The emotional and psychosocial impact on men and couples How couples like Paul and Julia navigate the unexpected and find resilience Whether you're directly facing male factor infertility, supporting a partner, or simply learning more about the different paths to parenthood, this conversation is a mix of story, science, and support. Note: This episode is the 3rd of a series of 5 that we are collaborating on with Jscreen in 2025.  Take a look at our previous two episodes here : Episode 157: Introduction to Genetics and Infertility Episode 166: Fragile X Syndrome: A Silent Factor in Infertility About Paul Kassebaum and Julia Cohen: Paul Kassebaum (Kass-eh-bomb) and Julia Cohen live in Westchester, NY where Paul is a quantum physicist and Julia is an economist. In 2021 they were forced to reconsider how to start a family when presented with a diagnosis of male factor infertility. They hope that by sharing both the medical and emotional aspects of their journey they can be a resource for other couples navigating the infertility space. About Dr. Ariel Moradzadeh: Dr. Ariel Moradzadeh attended medical school at The David Geffen school of medicine at UCLA. Following medical school, he completed his General Surgery internship and Urology residency at Cedars-Sinai Medical Center, where he developed his passion for men's health and male infertility. Following residency, he completed an andrology, men's health, male and infertility fellowship at UCLA, and he now works as a full-time reproductive Urologist at Cedars-Sinai. When he is not treating patients, he enjoys running, swimming, weight lifting and yoga. About Abbe Golding: Abbe Golding is a certified genetic counselor and works as a community education and outreach manager for JScreen. She is passionate about providing genetic knowledge that empowers individuals to make informed healthcare decisions. Abbe believes that accurate and relatable genetic information should be accessible to everyone. Abbe lives in Raleigh, North Carolina with her husband and daughter. Connect with JScreen -visit their website here -check out their instagram Connect with us: -Check out our Website -Follow us on Instagram and send us a message -Watch our TikToks -Follow us on Facebook -Watch us on YouTube -Connect with us on LinkedIn

Chuck P returns to Second Line Brewing in New Orleans and talks with owner Mark Logan about Taproom Talks, an educational series that the brewery is hosting in November. The first one is on Tuesday, November 4th, and focuses on men's sexual health led by Dr. Lawrence Jenkins, an Associate Professor of Urology & Director of Men's Health, Tulane University School of Medicine. The discussion will focus on sexual function and male infertility. This event is free and open to everyone.Also, 10% of all sales on November 4th will be donated to the Movember Foundation, supporting men's health initiatives across the globe. You can find out more information on this event by visiting Second Line Brewing's Facebook page.Become a supporter of this podcast: https://www.spreaker.com/podcast/the-abv-podcast--5595170/support.

Host: Darryl S. Chutka, M.D. Guest: Daniel M. Frendl, M.D., Ph.D. Prostate cancer is quite common in middle age and older men and represents the second most common malignancy diagnosed in this population. Only skin cancer is more common. Early diagnosis is important and carries an excellent prognosis. There are several management options available for localized disease and some new treatments which can be used for both aggressive and more advanced disease. When should active surveillance be used when prostate cancer has been diagnosed? How does radiation therapy compare to surgical prostatectomy regarding long-term outcomes and what are some of the newer treatment options available for advanced disease? These are some of the questions I'll be asking my guest, Daniel M. Frendl, M.D., Ph.D., a urologist from the Department of Urology at the Arizona campus of the Mayo Clinic as we discuss “Prostate Cancer”. Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts 

Send us a textUrologist Dr. Yaw Nyame joins Dr. Michael Koren to discuss bladder and prostate cancers. Dr. Nyame talks about his journey through college - including the choice between rock stardom and medical school - and how he got to the Fred Hutch Cancer Center in Seattle. Dr. Nyame explains symptoms, the history, and treatments for prostate and bladder cancer. He tells us "if you have blood in the urine, you definitely want to get to your primary care doctor." He also expands on gaps in cancer outcomes for Black men. Along the way, we weigh benefits and harms of PSA screening and talk honestly about sexual health after treatment.Show Note: Lynch syndrome is a genetic condition also known as hereditary nonpolyposis colorectal cancer (HNPCC). It represents an increased risk of several cancers, including colorectal, endometrial, gastric, ovarian, and pancreatic cancer. It is caused by an error in the DNA mismatch repair mechanism, which normally corrects for random insertions into the DNA code.Be a part of advancing science by participating in clinical research.Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.comListen on SpotifyListen on Apple PodcastsWatch on YouTubeShare with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.Follow us on Social Media:FacebookInstagramX (Formerly Twitter)LinkedInWant to learn more? Checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.comMusic: Storyblocks - Corporate InspiredThank you for listening!

Groin bulges, scrotal swelling, and nonpalpable testes are findings that often surface during routine well-child exams, and they can raise immediate questions for pediatricians and families alike. Is this normal? Will it resolve on its own? Or does it require surgical referral? In this episode, we take a closer look at three common genitourinary conditions in children: inguinal hernias, hydroceles, and undescended testes. We diagnose the details to help clarify the evaluation process, management strategies, and referral guidelines that every pediatrician should know.  This episode was recorded on the exhibit floor at the 2025 American Academy of Pediatrics Conference in Denver, Colorado. Joining us is Eric Bortnick, MD. He is a Urologist and Assistant Professor of Urology at the Yale School of Medicine.   Some highlights from this episode include:  How common these conditions are in the pediatric population  When pediatricians can make a difference in these patients lives, versus when referral is really necessary.  Key takeaways to performing a successful physical exam  Creating a safe space for proper diagnosis  For more information on Children's Colorado, visit: childrenscolorado.org. 

65% of men say they avoid seeking medical attention as long as possibleOnly 3 in 5 men go for their annual physical.And in Chicago, men are 10% less likely to have a primary care provider compared to women. And die 6 years earlier than women on average.On today's Block Club Chicago podcast, sponsored by Rush, doctor Zachary Glaser from Rush University's Department of Urology, on how 'Movember' can make a difference. Host - Jon HansenGuest - Dr. Zachary Glaser, Rush University Medical Center Want to donate to our non-profit newsroom? CLICK HEREWho we areBlock Club Chicago is a 501(c)(3) nonprofit news organization dedicated to delivering reliable, relevant and nonpartisan coverage of Chicago's diverse neighborhoods. We believe all neighborhoods deserve to be covered in a meaningful way.We amplify positive stories, cover development and local school council meetings and serve as watchdogs in neighborhoods often ostracized by traditional news media.Ground-level coverageOur neighborhood-based reporters don't parachute in once to cover a story. They are in the neighborhoods they cover every day building relationships over time with neighbors. We believe this ground-level approach not only builds community but leads to a more accurate portrayal of a neighborhood.Stories that matter to you — every daySince our launch five years ago, we've published more than 25,000 stories from the neighborhoods, covered hundreds of community meetings and send daily and neighborhood newsletters to more than 130,000 Chicagoans. We've built this loyalty by proving to folks we are not only covering their neighborhoods, we are a part of them. Some of us have internalized the national media's narrative of a broken Chicago. We aim to change that by celebrating our neighborhoods and chronicling the resilience of the people who fight every day to make Chicago a better place for all.

We have relied on PSA for decades, but what's next in precision screening for prostate cancer? In this episode of BackTable Urology, Dr. Jason Hafron from the Michigan Institute of Urology joins host Dr. Ruchika Talwar to discuss the evolving role of biomarkers and artificial intelligence in prostate cancer screening.---This podcast is supported by:Cleveland Diagnosticshttps://www.isopsa.com/---SYNPOSISTogether, Dr. Hafron and Dr. Talwar examine the ongoing challenges of PSA testing and the promise of next-generation blood-based biomarkers, including 4Kscore and IsoPSA tests. They explore how these advancements are reshaping detection, diagnosis, and risk stratification. The episode also highlights how these tools may improve active surveillance protocols, reduce unnecessary biopsies, and better personalize prostate cancer management for better outcomes.---TIMESTAMPS0:00 - Introduction2:23 - Limitations of PSA10:21 - Limitations of MRI18:08 - Overview of Biomarkers (IsoPSA, 4K, PHI, SelectMDx, MIPS, ExoDx)26:30 - Artificial Intelligence---RESOURCESProstate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trialhttps://jamanetwork.com/journals/jama/fullarticle/2817323 Using IsoPSA With Prostate Imaging Reporting and Data System Score May Help Refine Biopsy Decision Making in Patients With Elevated PSAhttps://pubmed.ncbi.nlm.nih.gov/36965817/ Clinical validation of IsoPSA, a single parameter, structure-focused assay for improved detection of prostate cancer: A prospective, multicenter studyhttps://pubmed.ncbi.nlm.nih.gov/35840465/

In this conversation, Dr. Dean Elterman, Associate Professor of Urology at the University of Toronto and a sub-specialist in functional urology, discusses benign prostatic hyperplasia (BPH), a common condition affecting men as they age. He explains the causes, symptoms, and various treatment options available, including medications, traditional surgeries, and minimally invasive procedures. The discussion also touches on the role of AI in improving treatment outcomes and the importance of lifestyle changes in managing BPH. Dr. Elterman emphasizes the need for awareness and proactive management of urinary symptoms.#prostatehealth

October 24, 2025 In episode 264 of the Urology Coding and Reimbursement Podcast, Scott and Mark Painter sit down with Ken Mitchell, PA-C, a nationally recognized expert in men's health and a champion for advanced practice providers (APPs) in urology. Ken shares insights on the growing urology workforce shortage, the evolving role of APPs, and recent payer challenges—like restrictions on APP-administered Xiaflex in Arkansas. He also introduces his nonprofit, Gynecology, which promotes men's health education and training. This episode is a must-listen for practices navigating workforce limitations, payer pushback, and the future of urologic care.Urology Advanced Coding and Reimbursement SeminarInformation and RegistrationPRS Coding and Reimbursement HubAccess the HubFree Kidney Stone Coding CalculatorDownload NowPRS Coding CoursesFor UrologistFor APPsFor Coders, Billers, and AdminsPRS Billing and Other Services - Book a Call with Mark Painter or Marianne DescioseClick Here to Get More Information and Request a Quote Join the Urology Pharma and Tech Pioneer GroupEmpowering urology practices to adopt new technology faster by providing clear reimbursement strategies—ensuring the practice gets paid and patients benefit sooner.         https://www.prsnetwork.com/joinuptpClick Here to Start Your Free Trial of AUACodingToday.com   The Thriving Urology Practice Facebook group.The Thriving Urology Practice Facebook Group link to join:https://www.facebook.com/groups/ThrivingPractice/ 

More on this awareness campaign by the UOAA at ostomy.org/take-action/ as referenced on OneLegUpAlex !

Dr. Dipen J. Parekh is a globally renowned urologic oncologist, healthcare innovator, and leader in academic medicine. He was appointed Executive Vice President for Health Affairs at the University of Miami and Chief Executive Officer of its health system (UHealth) on June 1, 2025. He remains Founding Director of the Desai Sethi Urology Institute and is an accomplished researcher and professor at the University of Miami Miller School of Medicine who holds the Victor A. Politano Endowed Chair in Urology and is widely celebrated for his groundbreaking contributions to the field of robotic-assisted urologic oncology. Having served as Chief Operating Officer of UHealth from 2020-2025, Chief Clinical Officer from 2017-2020, Chairman of the Department of Urology since 2012, Executive Dean of Clinical Affairs at the University of Miami Miller School of Medicine, and Director of Robotic Surgery for UHealth, Dr. Parekh brings a wealth of academic, clinical, administrative, and institutional experience to the role.Over the course of his career, Dr. Parekh has performed more than 6,000 robotic urologic cancer surgeries, making him one of the most experienced practitioners worldwide. He led the groundbreaking RAZOR trial, published in The Lancet in 2018, which established the efficacy of robotic-assisted radical cystectomy as comparable to open surgery for bladder cancer. He is an NCI funded surgeon scientist with over 200 peer reviewed publications in urologic oncology. His dedication to innovation has also included establishing advanced robotic surgery programs in academic centers across the globe.

Dr. Hoffman continues his conversation with Dr. Geo Espinosa, one of America's foremost integrative urologists.

Dr. Geo Espinosa, one of America's foremost integrative urologists, dishes on men's urinary problems, natural support for testosterone, and prostate cancer. Lifestyle factors—diet, exercise, sleep and stress reduction—play an important role in all phases of urological health. Dr. Geo explains how he interacts with conventional urologists on the faculty of NYU Langone Medical Center where he practices. Why are men's urinary problems not just a matter of prostate size? How can natural strategies alleviate urinary difficulties without the need for surgery or drugs? Besides saw palmetto, what nutraceuticals can benefit men with urinary problems? Are there really natural herbal alternatives to testosterone? For men with prostate cancer who are under active surveillance, is there anything more that can be done to minimize their chance of eventually needing surgery or radiation? What nutraceuticals, vitamins and minerals have anti-prostate cancer potential?

Urinary incontinence affects millions of women, yet many continue to suffer in silence due to stigma or the misconception that it's just a normal part of aging. Bladder control issues can impact women of all ages, and they are highly treatable, and there are real solutions that can help. On this episode of the Healthier You Podcast, Dr. Ashlee Williams welcomes Dr. Nwamaka Fadahunsi, a board-certified urologist at Kaiser Permanente, to discuss the causes of urinary incontinence and the many tools available to treat it. Dr. Fadahunsi explains the differences between stress and urge incontinence, debunks common myths, and offers practical guidance on what women can do at home. She also outlines the full range of treatment options, including physical therapy, medications, and outpatient procedures, helping women regain control and confidence without relying on pads or assuming surgery is the only answer.  Learn more about Nwamaka Fadahunsi, MD 

"Give Me the Green Life” isn't just a song lyric — it's a movement toward living fully, consciously, and healthily.In this powerful and revealing episode, we dive deep into the male side of fertility — a topic that's been ignored for far too long.Our expert guest joins us to discuss why sperm counts are dropping globally, what lifestyle factors are driving this crisis, and how men can reclaim their reproductive health naturally. From testosterone therapy pitfalls to the truth about saunas, marijuana, and modern stress, this episode uncovers it all.Dr. Justin Houman is a Board-Certified Urologist and fellowship-trained Men's Sexual and Reproductive Health specialist based in Los Angeles. His practice focuses on male fertility, erectile dysfunction, testosterone optimization, sexual performance, Peyronie's Disease, and minimally invasive procedures such as vasectomy reversals and penile implants.As an Assistant Professor of Urology at Cedars-Sinai Medical Center, Dr. Houman is dedicated to mentoring future physicians and advancing men's health through research, innovation, and education. His work has been featured in leading journals, including JAMA and the Journal of Sexual Medicine, and he has presented internationally on topics ranging from male fertility to the impact of wearable technology on health.A second-generation urologist, Dr. Houman completed his medical training at the University of Rochester and Cedars-Sinai, followed by a fellowship in Male Reproductive Medicine and Surgery at UCLA. Fluent in English, Spanish, and Farsi, he is committed to helping men enhance their quality of life through personalized, evidence-based care.

Enuresis, or bedwetting, is one of the most common concerns encountered in pediatrics. It can present as nighttime bedwetting, daytime urinary accidents, or a combination of both. Oftentimes, families and clinicians are left wondering what's typical and what's considered concerning. In this episode, we focus on the evaluation and management of enuresis in children. Each case is influenced by a range of factors including fluid intake, bowel habits, sleep quality and lifestyle routines. While first-line, non-pharmacologic strategies are the cornerstone of care, effective treatment requires attention to detail and a comprehensive approach. This episode was recorded on the exhibit floor at the 2025 American Academy of Pediatrics Conference in Denver, Colorado. In this episode, we are joined by Julie Cheng, MD, an Assistant Professor of Urology at Seattle Children's Hospital and the University of Washington.  Some highlights from this episode include:  Differentiating between types of enuresis  How key elements in pediatric history and physical examination can help diagnose the problem  Evidence-based first-line interventions and when to escalate care  The role behavioral factors, such as sleep or screen time, play in enuresis  For more information on Children's Colorado, visit: childrenscolorado.org.